Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence-

Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults

(2016) J. Rohayem et al.   Andrology

Pulsatile GnRH Is Superior to hCG in Therapeutic Efficacy in Adolescent Boys With Hypogonadotropic Hypogonadodism

(2015) Chunxiu Gong et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Validation of the FEEL-KJ: An Instrument to Measure Emotion Regulation Strategies in Children and Adolescents

(2015) Emiel Cracco et al.   PLoS One

Assessment of quality of life during gonadotrophin treatment for male hypogonadotrophic hypogonadism

(2014) Koji Shiraishi et al.   CLINICAL ENDOCRINOLOGY

Identifying the unmet health needs of patients with congenital hypogonadotropic hypogonadism using a web-based needs assessment: implications for online interventions and peer-to-peer support

(2014) Andrew A Dwyer et al.   Orphanet Journal of Rare Diseases

Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study

(2014) G. Rastrelli et al.   Andrology

Trial of Recombinant Follicle-Stimulating Hormone Pretreatment for GnRH-Induced Fertility in Patients with Congenital Hypogonadotropic Hypogonadism

(2013) Andrew A. Dwyer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis

(2012) Margaret Zacharin et al.   FERTILITY AND STERILITY

World Health Organization reference values for human semen characteristics*‡

(2009) Trevor G. Cooper et al.   HUMAN REPRODUCTION UPDATE

Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f®): long-term treatment in azoospermic men with hypogonadotropic hypogonadism

(2008) Alvin M. Matsumoto et al.   FERTILITY AND STERILITY

A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin

(2008) David W. Warne et al.   FERTILITY AND STERILITY

Seminal anti-Mullerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism

(2008) A.A. Sinisi et al.   HUMAN REPRODUCTION

Effects of an Early Postnatal Treatment of Hypogonadotropic Hypogonadism with a Continuous Subcutaneous Infusion of Recombinant Follicle-Stimulating Hormone and Luteinizing Hormone

(2008) P. Bougnères et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Induction of Spermatogenesis and Fertility during Gonadotropin Treatment of Gonadotropin-Deficient Infertile Men: Predictors of Fertility Outcome

(2008) Peter Y. Liu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM